HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kenshi Kamei Selected Research

mitemcinal

7/2008Mitemcinal (GM-611), an orally active motilin receptor agonist, improves delayed gastric emptying in a canine model of diabetic gastroparesis.
1/2008Oral mitemcinal (GM-611), an erythromycin-derived prokinetic, accelerates normal and experimentally delayed gastric emptying in conscious dogs.
1/2007Effects of mitemcinal (GM-611), an acid-resistant nonpeptide motilin receptor agonist, on the gastrointestinal contractile activity in conscious dogs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kenshi Kamei Research Topics

Disease

3Gastroparesis
07/2008 - 01/2007
2Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
08/2009 - 01/2007
1Diarrhea
08/2009
1Visceral Pain
03/2008
1Dyspepsia (Indigestion)
01/2007

Drug/Important Bio-Agent (IBA)

3motilin receptorIBA
08/2009 - 03/2008
3mitemcinalIBA
07/2008 - 01/2007
2MA-2029IBA
08/2009 - 03/2008
2MotilinIBA
08/2009 - 03/2008
2Cisapride (Propulsid)FDA Link
07/2008 - 01/2008

Therapy/Procedure

1Intravenous Infusions
03/2008
1Oral Administration
03/2008